Is ANAS or JNJ a better dividend investment in 2026?

ANAS currently yields 16666.67% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ANAS offers higher current income.

What is the dividend yield difference between ANAS and JNJ?

ANAS has a forward dividend yield of 16666.67% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 16663.31 percentage points.

Home › Compare › ANAS vs JNJ

ANAS vs JNJ: Dividend Comparison 2026

ANAS yields 16666.67% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ANAS wins by $8601297707047409664.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ANAS

● Live price

16666.67%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8601297707047409664.00M

Annual income

$8,500,961,637,704,150,000,000,000.00

Full ANAS calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ANAS vs JNJ

📍 ANAS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ANAS	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ANAS + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ANAS pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ANAS

Annual income on $10K today (after 15% tax)

$1,416,666.67/yr

After 10yr DRIP, annual income (after tax)

$7,225,817,392,048,527,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ANAS beats the other by $7,225,817,392,048,527,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ANAS + JNJ for your $10,000?

ANAS: 50%JNJ: 50%

100% JNJ50/50100% ANAS

Portfolio after 10yr

$4300648853523704832.00M

Annual income

$4,250,480,818,852,075,000,000,000.00/yr

Blended yield

98.83%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ANAS

No analyst data

Altman Z

2.1

Piotroski

0/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ANAS buys

JNJ buys

No recent congressional trades found for ANAS or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricANASJNJ

Forward yield	16666.67% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$8601297707047409664.00M ✓	$20.0K
Annual income after 10y	$8,500,961,637,704,150,000,000,000.00 ✓	$827.78
Total dividends collected	$8594666089931243520.00M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ANAS vs JNJ ($10,000, DRIP)

Year	ANAS Portfolio	ANAS Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$1,677,367	$1,666,666.67	$10,676	$355.77	+$1.67M → ANAS
2	$263,066,849	$261,272,066.46	$11,407	$389.39	+$263.06M → ANAS
3	$38,576,943,838	$38,295,462,310.00	$12,198	$426.53	+$38576.93M → ANAS
4	$5,289,656,888,585	$5,248,379,558,677.81	$13,056	$467.62	+$5289656.88M → ANAS
5	$678,235,585,150,030	$672,575,652,279,244.40	$13,987	$513.12	+$678235585.14M → ANAS
6	$81,321,145,183,775,540	$80,595,433,107,665,010.00	$14,998	$563.56	+$81321145183.76M → ANAS
7	$9,118,299,079,523,715,000	$9,031,285,454,177,076,000.00	$16,098	$619.52	+$9118299079523.70M → ANAS
8	$956,159,646,381,740,000,000	$946,403,066,366,649,700,000.00	$17,295	$681.69	+$956159646381740.00M → ANAS
9	$93,772,027,423,605,150,000,000	$92,748,936,601,976,690,000,000.00	$18,599	$750.82	+$93772027423605152.00M → ANAS
10	$8,601,297,707,047,409,000,000,000	$8,500,961,637,704,150,000,000,000.00	$20,022	$827.78	+$8601297707047409664.00M → ANAS

ANAS vs JNJ: Complete Analysis 2026

ANAS — Stock

Alternaturals Inc. is an agricultural technology group. We launch a pollution-free, high-efficiency way of large-scale planting, provide consumers with the healthiest and safest products. Our plant factory using sensing components, integrating information and communication technology (ICT), Internet of Things (IOT), big data and supplemented by agricultural ERP systems, combine with green energy such as wind and solar energy. Our mission is to provide an environmentally friendly agricultural solutions.

Full ANAS Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ANAS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ANAS vs SCHD ANAS vs JEPI ANAS vs O ANAS vs KO ANAS vs MAIN ANAS vs ABBV ANAS vs MRK ANAS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.